This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
Contraception vaccine stimulates antibody to chorionic gonadotropin
A contraceptive vaccine is showing promise in preliminary studies being carried out by G. P. Talwar, MD, and co-workers at the All-India Institute of Medical Sciences, New Delhi."The first human studies were done in women who had been surgically sterilized for medical reasons, and so the vaccine's actual efficacy is not known. But the vaccine did cause the women to form antibodies to human chorionic gonadotropin," Sheldon J. Segal, PhD, reported to a science writers' briefing in New York.Dr Segal is vice-president and director of the biomedical division of the Population Council at Rockefeller University in New York. The council's International Committee for Contraception Research has been helping Dr Talwar's group in carrying out the research in cooperation with other investigators. The briefing at which he spoke was sponsored by the Ford Foundation to mark the publication of Reproduction and
Medical News. JAMA. 1977;237(6):519–524. doi:10.1001/jama.1977.03270330009001
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: